Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2017 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Receives Notice of Acceptance for Key Metabolic Patent in Australia

MELVILLE, N.Y., April 20, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies,...
April 20, 2017 07:55 ET | Source: Earth Science Tech, Inc.

ETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017

Hollywood, April 20, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST), an innovative biotech company focused on cannabis (industrial hemp), cannabinoid research and development,...
April 19, 2017 08:00 ET | Source: Pluristem Therapeutics Inc.

Pluristem Reaches Milestone of 100 Granted Patents, Including Coverage of Leading Indications in Major Markets

In addition, Pluristem has over 110 pending patent applications.The patents portfolio covers over 30 different innovations across major markets. HAIFA, Israel, April 19, 2017 (GLOBE NEWSWIRE) --...
April 19, 2017 07:30 ET | Source: Kura Oncology, Inc.

Kura Oncology Granted U.S. Patent for Clinical-Stage ERK Inhibitor, KO-947

LA JOLLA, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology,...
April 18, 2017 08:30 ET | Source: Cellectar Biosciences, Inc.

Cellectar Biosciences Receives Japanese Patent for CLR 131 and CLR 125 for the Treatment of Cancer Stem Cells

MADISON, Wis., April 18, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the Japanese...
April 18, 2017 08:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®

RedHill received Notices of Allowance from the United States Patent and Trademark Office (USPTO) for two new patents covering BEKINDA® (RHB-102), expected to be valid until at least 2034, once...
April 18, 2017 08:00 ET | Source: Posit Science

New Patent on Software as a Therapeutic for Depression and other Disorders

SAN FRANCISCO, April 18, 2017 (GLOBE NEWSWIRE) -- The US Patent Office has issued a comprehensive patent to Posit Science for inventions utilizing brain training software to address depression, mood...
April 17, 2017 09:15 ET | Source: Repros Therapeutics Inc.

Repros Announces the Issuance of New U.S. Patent Relating to Treatment Using Off Drug Intervals For Certain Uterine Conditions

THE WOODLANDS, Texas, April 17, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced the issuance of a new patent, U.S. Patent number 9,616,074 (the ‘074 patent), that...
April 17, 2017 08:45 ET | Source: Fuisz Pharma LLC

FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies (Amended Press Release)

Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of manufacture...
April 17, 2017 07:30 ET | Source: Fuisz Pharma LLC

FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies

Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of...